|
|
|
|
Office of Innovation and Entrepreneurship Reports Solid Year of Results and Growth of Innovation Ecosystem |
|
Pitt innovators continued to translate their ideas and discoveries into products and services at a brisk pace in Fiscal 2022, a year in which the univerity’s and regions innovation and entrepreneurship ecosystem received several pieces of good news.
|
|
Read More > |
|
|
LifeX Assumes State Life Sciences Greenhouse Designation |
|
Life science capital growth company established by Pitt unlocks new source of funding for regional life science startups.
|
|
Read More > |
|
|
|
|
|
|
|
Lumis Corp Expands Augmented Reality Training Platform |
|
|
|
With a new CEO to help drive growth and investment, Lumis is working on buildings its relationship with existing customers by expanding into new healthcare specialties. |
|
|
|
|
|
|
|
|
|
Upcoming Events |
|
|
"APO Technologies: From Invention Disclosure to Failed Startup"
|
Dr. Goeran Fiedler
Online via Zoom |
SHRS Innovation Seminar |
1:00 pm |
|
|
|
|
|
|
|
Blockchain & IP
USPTO Event |
Online |
|
|
Investigate the intersection of blockchain, patents, and open source and the interesting legal issues they present.
|
4:00 -5:00 pm |
|
|
|
|
|
|
Network + Grow: Building & Scaling a Small Business |
In-Person:
Ascender 6401 Penn Avenue Pittsburgh, PA 15206 |
|
|
|
8:30 am |
|
|
|
|
|
|
|
|
Pitt Innovators in the News |
|
Replay launches with $55 million seed investment |
Globe Newswire |
Genomic medicine company has licensed the rights to engineered virus vector technology from the lab of Pitt professor Joseph Glorioso, among other technologies it is developing. |
Read More > |
|
|
|
|
|
|
|
Avista partners with Roche to develop gene therapy to treat eye disease |
Fierce Biotech |
In a deal that could eventually be worth up to $1 billion, Roche has partnered with Pitt startup Avista Therapeutics to develop technology from the research of Pitt professors Leah Byrne and Jose Sahel. |
Read More > |
|
|
|
|
|
|
|
KaliVir inks partnership agreement to develop cancer fighting viruses |
PR Newswire |
Under the terms of the agreement with Roche, KaliVir will generate oncolytic vaccinia virus product candidates derived from the company's platform expressing Roche proprietary therapeutic transgenes. Roche will have exclusive license to discover, develop and commercialize the products worldwide. |
Read More > |
|
|
|
|
|
|
|
Novasenta raises $40 million to advance cancer therapies |
PR Newswire |
Pitt startup is mapping the tumor microenvironment to create immunotherapies that enable the body’s own immune system to fight cancer. |
Read More > |
|
|
|
|
|
|
Commercialization and Partnering Opportunities |
|
Can Your Research Discovery Impact People’s Lives? Find out in First Gear. |
|
|
The fall cohort of the Innovation Institute’s First Gear program begins Sept. 6. Through a series of workshops and working one-on-one with an experienced business mentor, Pitt innovators can uncover the commercial potential of their ideas and discoveries. |
|
|
|
|
Michael G. Wells Healthcare Competition |
|
|
This competition is a great way to explore your innovation's commercial potential and is an invaluable learning experience for graduate students or postdocs. Students must apply with a faculty sponsor and represent a technology that has resulted from Pitt research. Up to $40,000 is available to the participating University departments. |
|
|
|
|
|
LifeX accepting applications for startup accelerator program |
|
|
This healthcare specific curriculum is designed to prepare teams for commercialization outside of the academic environment, including developing an investable pitch and commercialization plan, direct support from dozens of experienced entrepreneurs and industry experts, and an opportunity to win cash + service prizes for continued growth after the program. |
|
|
|
|
|
|
|
Alzheimer's is a progressive neurodegenerative disease with devastating consequences for the patient and their caregivers. Researchers at the University of Pittsburgh are working to develop new therapeutics and methodologies to prevent, diagnose, and slow or reverse the progress of Alzheimer's Disease. |
|
|